Trial Profile
A Randomized, Single-dose, Two-way Crossover Study to Assess the Bioequivalence of Meloxicam Capsules 15 mg (Mobic(R) Capsules 15 mg) Versus Meloxicam Tablets 15 mg (Mobic(R) Tablets 15 mg) Administered to Healthy Adult Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2014
Price :
$35
*
At a glance
- Drugs Meloxicam (Primary) ; Meloxicam (Primary)
- Indications Ankylosing spondylitis; Back pain; Gout; Juvenile rheumatoid arthritis; Neuropathic pain; Osteoarthritis; Periarthritis; Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 16 Jul 2014 New trial record